title: Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area.
abstract: To examine whether biomarkers such as sister chromatid exchanges (SCEs) and chromosome aberrations (CAs) can predict cancer development, a nested case-control study was performed in a blackfoot endemic area with a known high cancer risk. A cohort of 686 residents was recruited from three villages in the blackfoot endemic area. Personal characteristics were collected, and venous blood was drawn for lymphocyte culture and stored in a refrigerator. The vital status and cancer development were followed using the National Death Registry, Cancer Registry, and Blackfoot Disease Registry. The follow-up period was from August 1991 to July 1995. During this 4-year period, 31 residents developed various types of cancer. Blood culture samples from nine of these subjects were unsuitable for experiments due to improper storage. Finally, a total of 22 cancer cases had cytogenetic samples that could be analyzed. Twenty-two control subjects were selected from those who did not develop cancer in the study period, and these subjects were matched to cases by sex, age, smoking habits, and residential area. The results showed that there was no significant difference in the frequencies of SCE and chromatid-type CAs between the case and control groups. However, the frequencies of chromosome-type CAs, e.g., chromosome-type gaps, chromosome-type breaks, chromosome-type breaks plus exchanges, total chromosome-type aberrations, and total frequencies of CAs in the case group, were significantly higher than those in the control group (P < 0.05). The odds ratio of cancer risk in subjects with more than zero chromosome-type breaks was 5.0 (95% confidence interval = 1.09-22.82) compared to those with zero chromosomal breaks. The odds ratios for more than zero chromosome-type breaks plus exchanges and a frequency of total chromosome-type aberrations of >1.007% were 11.0 and 12.0, respectively (P < 0.05). Subjects with a total CA frequency of >4.023% had a 9-fold increase for cancer risk. These results indicate that chromosome-type CAs are good biomarkers for the prediction of cancer development, whereas SCEs and chromatid-type CAs cannot predict cancer risk.
authors: Department of Public Health, National Defense Medical Center, Taipei, Taiwan, Republic of China.
authors: S H
authors: SH
authors: Liou
authors: J C
authors: JC
authors: Lung
authors: Y H
authors: YH
authors: Chen
authors: T
authors: T
authors: Yang
authors: L L
authors: LL
authors: Hsieh
authors: C J
authors: CJ
authors: Chen
authors: T N
authors: TN
authors: Wu
mesh_terms: D000328:Adult; D000368:Aged; D020261:Arsenic Poisoning; D015415:Biomarkers; D016022:Case-Control Studies; D002869:Chromosome Aberrations; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009369:Neoplasms / Q000209:etiology*; D012854:Sister Chromatid Exchange; D013624:Taiwan; D014874:Water Pollutants, Chemical / Q000506:poisoning*
chemical_list: D015415:Biomarkers; D014874:Water Pollutants, Chemical